The observations that both CF carriers (CF parents) and patients with CF are at higher risk of CF-related conditions than people without CFTR mutations suggest that distinct CFTR-related mechanisms are at play in both heterozygous and homozygous individuals (27, 28). The gene discussed is CFTR; the disease is cystic fibrosis.